HOME > MARKETS > MARKET COMMENTARY
  MARKET COMMENTARY
EQUITY
Indegene gains as its arm inks pact to acquire 100% stake in Warn and Co
Oct-17-2025

Indegene is currently trading at Rs. 544.45, up by 5.45 points or 1.01% from its previous closing of Rs. 539.00 on the BSE.

The scrip opened at Rs. 539.80 and has touched a high and low of Rs. 545.70 and Rs. 537.80 respectively. So far 4788 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 735.00 on 08-Nov-2024 and a 52 week low of Rs. 485.15 on 07-Apr-2025.

Last one week high and low of the scrip stood at Rs. 558.75 and Rs. 531.20 respectively. The current market cap of the company is Rs. 13005.96 crore.

The Institutions and Non-Institutions held 17.25% and 82.75% stake in the company, respectively.

Indegene’s wholly owned subsidiary -- Indegene Ireland has signed a Share Purchase Agreement (SPA) to acquire 100% equity shares in Warn and Co. The objective of acquisition is to further augment Indegene's capabilities and offerings in life sciences consulting business.

Indegene provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech and medical devices companies, that assist them with drug development and clinical trials, regulatory submissions, pharmacovigilance and complaints management, and the sales and marketing of their products.

  RELATED NEWS >>